课题基金 / 基金详情

MAP-PC: An Addiction Medicine Training Course for Primary Care Pain Treatment

MAP-PC: An Addiction Medicine Training Course for Primary Care Pain Treatment
MAP-PC:初级保健疼痛治疗成瘾医学培训课程
批准号:
8000786
负责人:
Emil J. Chiauzzi
金额:
$43.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-15 至 2012-03-31

项目摘要

项目成果

Emil J. Chiauzzi的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):第二阶段为初级保健医生开发和测试一个在线CME项目,称为初级保健中的成瘾和疼痛管理(MAP-PC)。多项研究支持阿片类药物在治疗急性疼痛和与癌症相关的疼痛方面的效用,但医生对慢性疼痛的处方仍然不足。许多医生担心病人可能滥用药物、潜在的责任和监管机构的谴责。不愿意开阿片类药物在初级保健医生(pcp)中尤其明显,他们治疗的疼痛患者比例很高。初级保健医生采用疼痛管理和成瘾医学原则的能力的提高将导致更适当地使用阿片类药物,以及患者更成功的疼痛治疗结果,特别是那些潜在或过去有药物滥用/滥用的患者。FDA促进阿片类药物风险评估和缓解策略(REMS)可能需要进一步发展医生的继续教育计划。不幸的是,对于治疗慢性疼痛患者的医生缺乏这样的培训。随着互联网和业务逻辑(决策分支)软件的出现,有技术可以吸引和教育寻求建立疼痛治疗技能的医生。利用这项技术,MAP-PC将帮助医生:(1)提高疼痛管理和成瘾药物技能,帮助有阿片类药物滥用或误用风险的疼痛患者;(2)在知情的情况下为患者做出适当使用阿片类药物的决定;(3)处理阿片类药物治疗疼痛过程中出现的临床挑战。在第二阶段,我们将完成MAP-PC的开发和研究措施。疗效研究将随机分为两个条件:(1)实验(MAP-PC)和(2)对照(基于在线文本的CME)。实验组和对照组将进行基线评估、干预后和三个月的随访。第二阶段涉及测试假设,相对于对照条件,暴露于MAP-PC的医生将:(1)提高慢性疼痛患者阿片类药物风险管理的专业知识,(2)提高慢性疼痛患者阿片类药物风险管理的自我效能感,(3)改善临床实践行为,识别和解决疼痛患者阿片类药物风险问题。我们还将测试次要假设,即相对于对照条件,暴露于MAP-PC的医生将显著感知:(1)为慢性疼痛患者开阿片类药物的障碍减少,(2)不愿意为慢性疼痛患者开阿片类药物(改变信念)。最后,我们将测试用户对MAP-PC的满意度和接受程度。
英文摘要
DESCRIPTION (provided by applicant): This Phase II proposes the development and testing of an online CME program for primary care physicians called Managing Addiction and Pain in Primary Care (MAP-PC). Multiple studies have supported the utility of opioids in the treatment of acute pain and pain related to cancer, but they continue to be under-prescribed by physicians for chronic pain. Many physicians are concerned about possible abuse by patients, potential liability, and censure by regulatory agencies. The reluctance to prescribe opioids is particularly evident among primary care physicians (PCPs), who treat a high proportion of pain patients. An improvement in the ability of primary care physicians to adopt pain management and addiction medicine principles would lead to more appropriate use of opioids, along with more successful pain treatment outcomes in patients, especially those with potential or past substance misuse/abuse. The promotion of Risk Evaluation and Mitigation Strategies (REMS) for opioids by the FDA will likely require further development of continuing education programs for physicians. Unfortunately, there is a lack of such training for physicians treating chronic pain patients. With the advent of the Internet and business logic (decision branching) software, there is technology available to engage and educate physicians seeking to build pain treatment skills. Using this technology, MAP-PC will help physicians: (1) increase pain management and addiction medicine skills with pain patients at risk of opioid abuse or misuse; (2) make informed decisions about the appropriate use of opioids for their patients; and (3) manage clinical challenges that arise during the course of pain treatment with opioids. In Phase II, we will complete the development of MAP-PC and the study measures. The efficacy study will involve randomization to two conditions: (1) Experimental (MAP-PC) and (2) Control (online text-based CME). The Experimental and Control groups will undergo a baseline assessment, post-intervention, and three-month follow- ups. Phase II involves testing the hypotheses that, relative to the control condition, physicians exposed to MAP-PC will: (1) improve expertise in managing opioid risk in chronic pain patients, (2) enhance self-efficacy in managing opioid risk in chronic pain patients, and (3) improve clinical practice behaviors with respect to identifying and addressing opioid risk issues in pain patients. We will also test the secondary hypotheses that, relative to the control condition, physicians exposed to MAP-PC will perceive significantly: (1) fewer barriers to prescribe opioids for chronic pain patients, and (2) reduced reluctance to prescribe opioids for chronic pain (changed beliefs). Finally, we will test user satisfaction with and acceptance of MAP-PC. PUBLIC HEALTH RELEVANCE: Pain is often under-treated due to primary care physicians' ambivalence about prescribing opioid medications for fear that the patient might abuse or become addicted to the medication. This is particularly true for patients with potential or past substance misuse/abuse. This research project will culminate in the development and testing of an interactive Continuing Medical Education (CME) course, Managing Addiction and Pain in Primary Care (MAP-PC), that teaches primary care physicians about pain management and addiction medicine skills with pain patients at risk of opioid abuse or misuse. If successful, this program can enhance public health by helping physicians to offer needed treatment to chronic pain patient while managing the risk of opioid misuse/abuse more effectively.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Clinical Decision Support Tool for Electronic Health Records
  • 批准号:
    8200082
  • 项目类别:
  • 资助金额:
    $32.26万
  • 财政年份:
    2011
  • 负责人:
    Emil J. Chiauzzi
  • 依托单位:
ASI-MV Counselor Solutions: An Online Program for Evidence Based Treatment
  • 批准号:
    7800757
  • 项目类别:
  • 资助金额:
    $25.76万
  • 财政年份:
    2010
  • 负责人:
    Emil J. Chiauzzi
  • 依托单位:
ASI-MV Solutions: A Tailored Program for Substance Abusers in Early Recovery
  • 批准号:
    7609544
  • 项目类别:
  • 资助金额:
    $21.69万
  • 财政年份:
    2009
  • 负责人:
    Emil J. Chiauzzi
  • 依托单位:
ASI-MV Solutions: A Tailored Program for Substance Abusers in Early Recovery
  • 批准号:
    7909987
  • 项目类别:
  • 资助金额:
    $88.27万
  • 财政年份:
    2009
  • 负责人:
    Emil J. Chiauzzi
  • 依托单位:
海外基金